Literature DB >> 15211121

Endovascular stent grafts for acute blunt aortic injury.

M B Dunham1, David Zygun, P Petrasek, John B Kortbeek, Riyad Karmy-Jones, Randy D Moore.   

Abstract

BACKGROUND: Endovascular stent grafting (EVSG) has emerged as a new treatment for aortic disease and has recently been applied to the treatment of acute blunt aortic injury (BAI). The purpose of this study was to determine the outcome of EVSG for patients with BAI at two tertiary (Level I) trauma centers.
METHODS: A retrospective review of patients treated between January 1, 1999, and February 1, 2003, at two centers, Calgary Health Region (Calgary, Alberta) and Harborview Medical Center (Seattle, WA), with EVSG for acute BAI is reported. Variables assessed included age, sex, Injury Severity Score, total length of stay (LOS), intensive care unit LOS, operative technique, complications, technical success, mortality, and follow-up data.
RESULTS: Twenty-eight patients treated with EVSG for BAI were identified during this period. Twelve patients were excluded because injuries occurred more than 30 days before grafting (n = 7) or under a different protocol (n = 4), or the procedure was performed in a different center (n = 1). Sixteen patients with acute BAI were reviewed. The mean Injury Severity Score was 36.9 (SD, 17.0), with a median intensive care unit LOS of 7.5 days (interquartile range, 1-17 days) and total LOS of 24.5 days (interquartile range, 7-41 days). Mean follow-up was 10.7 months (range, 3-30 months). Technical success was achieved in all patients, no graft-related complications have been detected during follow-up, and no patient developed postoperative paraplegia. One postoperative mortality occurred secondary to severe comorbid injury. A single patient with a preoperative traumatic carotid dissection demonstrated a postoperative stroke, and one patient required thoracentesis for a pleural effusion.
CONCLUSION: Repair of BAI with EVSG can be performed safely in patients with BAI. Mortality, morbidity, and especially paraplegia are reduced. Further long-term studies are required to support the routine use of EVSG technology for BAI.

Entities:  

Mesh:

Year:  2004        PMID: 15211121     DOI: 10.1097/01.ta.0000123039.92225.e5

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  8 in total

1.  Placement of endovascular stent-grafts for emergency repair of acute traumatic aortic rupture: a single-centre experience.

Authors:  I E Steingruber; B V Czermak; A Chemelli; B Glodny; J Bonatti; W Jaschke; P Waldenberger; M Rieger; B Neuhauser
Journal:  Eur Radiol       Date:  2006-11-18       Impact factor: 5.315

2.  Natural history of minimal aortic injury following blunt thoracic aortic trauma.

Authors:  Biniam Kidane; Daniel Abramowitz; Jeremy R Harris; Guy DeRose; Thomas L Forbes
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

3.  Endovascular approach to acute aortic trauma.

Authors:  Riyad Karmy-Jones; Desarom Teso; Nicole Jackson; Lisa Ferigno; Robert Bloch
Journal:  World J Radiol       Date:  2009-12-31

4.  Thoracic aortic and great vessel trauma and its management.

Authors:  Simon J McPherson
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

5.  Current management of traumatic rupture of the descending thoracic aorta.

Authors:  Riyad Karmy-Jones; Nichole Jackson; William Long; Alan Simeone
Journal:  Curr Cardiol Rev       Date:  2009-08

6.  Evaluation of the outcome of traumatic thoracic aortic rupture in patients in a trauma and critical care center.

Authors:  Masahiko Okada; Makoto Kamesaki; Manabu Mikami; Yoshihiro Okura; Jun Yamakawa; Kazuhiro Sugiyama; Yuuichi Hamabe
Journal:  Ann Vasc Dis       Date:  2013-02-28

Review 7.  Endovascular stent-graft placement for vascular failure of the thoracic aorta.

Authors:  Yoshihiko Kurimoto; Kiyofumi Morishita; Yasufumi Asai
Journal:  Vasc Health Risk Manag       Date:  2006

Review 8.  Blunt thoracic aortic injury - concepts and management.

Authors:  Nicolas J Mouawad; Joseph Paulisin; Stephen Hofmeister; Matthew B Thomas
Journal:  J Cardiothorac Surg       Date:  2020-04-19       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.